Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Traws Pharma, Inc.ONTX · Entity 8032 | SVP Corp Dev & Gen Counsel | February 07, 2022 | February 09, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Traws Pharma, Inc.
Report date February 07, 2022 · Filed February 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.82 · Expires 2032-02-07 | Direct | 54,050 |
Reported balance
After 2022-02-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-07 · Grant · Acquired 54,050 · Balance 54,050 F1: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,633 |
Reported balance
After 2022-02-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-07 · Grant · Acquired 17,633 · Balance 17,633 F3: Each restricted stock unit is convertible into one share of common stock. F2: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. |
Filing footnotes · ownership attribution and instrument terms
F1: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
F2: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
F3: Each restricted stock unit is convertible into one share of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2022 Filed Feb 9, 2022 21:38 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantRestricted Stock Units · Derivative | 17,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000962 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,633 Underlying: Common stock · 17,633 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:38 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 54,050 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001179110-22-000962 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,050 Underlying: Common stock · 54,050 shares Expires 2032-02-07 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| January 28, 2022 Filed Jan 31, 2022 13:41 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 1,500 | $1.67 | $2,505.00 |
DisclosureSEC source: 0001179110-22-000652 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,514 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| January 21, 2022 Filed Jan 24, 2022 13:40 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 1,500 | $2.02 | $3,030.00 |
DisclosureSEC source: 0001179110-22-000564 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,014 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| January 14, 2022 Filed Jan 18, 2022 14:12 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 1,500 | $2.20 | $3,300.00 |
DisclosureSEC source: 0001415889-22-000588 · form4-01182022_060148.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP CORP DEV & GEN COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,514 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| January 07, 2022 Filed Jan 10, 2022 13:39 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 1,500 | $2.39 | $3,585.00 |
DisclosureSEC source: 0001179110-22-000350 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,014 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 14:20 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon stock | 1,000 | $3.16 | $3,160.00 |
DisclosureSEC source: 0001415889-21-005425 · form4-11232021_061136.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP CORP DEV & GEN COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,514 F1 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 13:45 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | OtherWarrant (right to purchase) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010259 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-11-25 F2 · shares: The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 13:45 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | OtherCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001179110-21-010259 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,514 F1 · balance_after: Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 12:27 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 2,381 | $4.20 | $10,000.20 |
DisclosureSEC source: 0001179110-21-008982 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F1 · balance_after: Includes 4,334 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 23:12 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantRestricted Stock Units · Derivative | 13,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007922 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,400 Underlying: Common stock · 13,400 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 23:12 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 40,000 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001179110-21-007922 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2031-08-02 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:29 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Appreciation Right · Derivative | 208,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001179110-21-002008 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,000 Underlying: Common Stock · 208,000 shares Expires 2031-02-17 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. F2 · derivative.underlying: These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:57 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 12,000 | $1.00 | $12,000.00 |
DisclosureSEC source: 0001179110-21-001785 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,000 F1 · balance_after: Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 14:00 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 30,000 | $0.32 | $9,600.00 |
DisclosureSEC source: 0001179110-20-011839 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · balance_after: Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 22:09 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 20,000 | $0.26 | $5,120.00 |
DisclosureSEC source: 0001179110-20-011469 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 F1 · balance_after: Includes 35,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 21:51 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Appreciation Right · Derivative | 375,600 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001179110-20-008213 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,600 Underlying: Common Stock · 375,600 shares Expires 2030-07-09 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| May 19, 2020 Filed May 20, 2020 13:19 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 15,000 | $0.37 | $5,550.00 |
DisclosureSEC source: 0001179110-20-006359 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 14:08 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 60,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001179110-19-013140 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · VP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-12-20 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 12:46 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseWarrant (right to purchase) · Derivative | 75,000 | Not disclosed Strike: $0.20 | Not disclosed |
DisclosureSEC source: 0001179110-19-012054 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · VP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2024-11-25 F1 · price: The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 12:46 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 75,000 | $0.20 | $15,000.00 |
DisclosureSEC source: 0001179110-19-012054 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · VP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · price: The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.